Study ID: Medimmune CD-ON-MEDI-551-1019
Description:

A phase 2 Open-label Study of MEDI-551 and bendamustine vs Rituximab and Bendamustine in Adults with Relapsed or Refractory CLL

Location:
Fargo Region
Principal Investigator:
Amit Panwalkar, MD
Disease:
CCL
Stage:
N/A

Status:

Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.

Back to Clinical Trials list